Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Bipolar Depression and Inflammation
NCT02765100Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of minocycline in bipolar disorder (BD) and major depressive disorder (MDD), sponsored by Weill Cornell Medicine. Primary endpoint: Hamilton Depression Scale at 8 weeks. Started Oct 2014; status: completed.
02
Drugs
minocycline
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02765100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765100.